Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BMO 2019 Prescriptions for Success Healthcare Conference in New York, NY on Tuesday, June 25,...

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced it will present data from two of its movement disorder programs, including INGREZZA® (valbenazine) capsules, the first U.S. Food and...

Jet Linx, the third largest aircraft management company in the United States (Part 135), further established its position today as the leading company in private aviation by dedicating the entire...

Slickdeals, the leading crowdsourced shopping platform, today released its second annual "Best Value for Gamers" awards, highlighting products, brands and services that offer unmatched benefits to...

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according to results announced at the symposium titled...